Fisioterapia respiratoria en fibrosis pulmonar por covid-19.

Abstract

Covid-19 has become a very harmful pathology to health, causing complications even in the chronic stage of the disease; one of these sequelae is pulmonary fibrosis, which generates a thickening of the alveolar tissue, thus leading to malfunction of the respiratory pump, musculoskeletal disorders and decreased quality of life. Objective: To determine the benefits obtained by respiratory physiotherapy in patients with pulmonary fibrosis due to Covid-19 in the subacute stage. Materials and methods: This study has a quantitative approach, with an explanatory scope and a non-experimental cross-sectional design. The study sample consisted of 20 individuals from the Covid-19 clinical area of the HTMC, who were subdivided equally into the control and intervention groups. Results: Initially, the population showed very unfavorable ranges in both study groups. Finally, after the physiotherapeutic intervention, an improvement in aspects such as functional respiratory capacity, degree of dyspnea, and quality of life was observed in the intervention group. Conclusion: it was possible to verify the improvement in the intervention group compared to the control group in which little or no improvement was found in the previously mentioned variables, these results were thanks to the determination of the researchers and the support provided by both professionals of the area as well as from the patients themselves.